The Southern Society for Clinical Investigation logo for print

6359 Tribute Lane
Dora, AL 35062

Phone: 205-648-8429
Cell: 205-566-6090

Contact Us
Join Now

Pronabesh DasMahapatra, MBBS, MPH

Pronabesh DasMahapatra, MBBS, MPH

Health Economics & Value Assessment

Rare Disease & Rare Blood Disorders
50 Binney Street
Cambridge, MA 02142

Phone: 617-758-9513

Assistant: Aileen Geary
Phone: () -

Member Since: 2020


Head of Heath Economics and Value Assessment, Rare Disease and Rare Blood Disorder, Sanofi



Clinical Interest(s)

Research Interest(s)

  • Outcomes research
  • Epidemiology
  • Biostatistics
  • Cardiovascular Health
  • Rare disease

Current / Former SSCI Roles


About Pronabesh DasMahapatra, MBBS, MPH

Pronabesh DasMahapatra is the Head of Rare Disease and Rare Blood Disorder in Health Economics and Value Assessment at Sanofi. A medical doctor and epidemiologist by training, Pronabesh held senior scientific roles in the healthcare industry and was an integral member of the PatientsLikeMe research team. Pronabesh specializes in health outcomes research and pharmacoeconomics with special interest in advanced biostatistical modeling, real-world data, patient-reported outcomes, and digital technologies for health assessment. After medical school, Pronabesh served as a medical officer for three years. He subsequently began his research career at the Center for Cardiovascular Health, Tulane University, studying the evolution of cardiometabolic risk from birth to middle age. At Sanofi, Pronabesh leads the global evidence generation strategy for several investigational and marketed products that address high unmet medical needs. His ambition is to amalgamate clinical insights and machine learning techniques towards the advancement of patient-centered digital tools that evolve the scientific understanding of clinical, economic and humanistic aspects of disease. His work is documented in biomedical journals and books.


The SSCI Thanks Its Sponsors

  • Elsevier sponsors The Southern Society for Clinical Investigation
  • AstraZeneca sponsors The Southern Society for Clinical Investigation